Arkema Increases Global Pebax Elastomer Production Capacity by 40%
Arkema has increased global production capacity for Pebax elastomers by 40% at its Serquigny plant in France, where products are mainly used in the sports and consumer goods markets.
Arkema launches new Pebax elastomers unit at its Serquigny plant in France. The new unit uses the latest industrial process designs to produce the biocyclic Pebax Rnew and classic Pebax elastomer ranges.
These advanced materials are widely used in sports equipment such as running shoes, soccer shoes and ski boots, as well as in electronic equipment and other specialty markets such as antistatic additives and medical devices.
"We are excited to begin expanding our Pebax elastomers capacity. This is a great opportunity for us to meet growing demand from existing and new applications while improving our processes and water consumption on site will be reduced by approximately 25%," commented Erwoan Pezron, Senior Vice-President of Arkema's High-Performance Polymers Business Line.
2026-08-08
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Arkema Triples Transparent Polyamide Capacity in Singapore: a Bet on Virtual Reality Growth or a Move to Strengthen Supply Resilience?
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
Arkema Divests PVC Additives Business to Focus Resources on High-Performance Materials Market
-
Arkema Invests $60 Million to Upgrade its US FluoroSpecialties Production Unit
-
Arkema Continues to Increase Investment in Singapore, Investing $20 Million to Build a Transparent Polyamide Plant
-
Arkema Receives ISCC PLUS Certification for Mass Balance of UV-LED-EB Resin Production
-
Arkema Announces Production of Bio-Based Performance Rheology Additives in Europe
-
Arkema Launches Acrylic Acid Purification Project
-
Arkema Invests $20 Million in North America to Increase PVDF Production Capacity by 15%
-
ALBIS to Distribute Arkema’s High-Performance Medical-Grade Polymers
Recommend Reading
-
Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
-
Australia New Zealand Approve GM Enzyme Stevia Sweetener From China for Food Use
-
Lula’s Disapproval Hits 2024 Low at 51 Percent Support Surges Among Poor and Women After US Tariff Dispute
-
“Milk Sugar 2.0” Cleared for Takeoff: EU Greenlights Next-Gen Human-Identical Oligosaccharide for Infant Nutrition
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Premium Global Chemical Sourcing Requests (30 Mar-1Apr, 2026)
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
As Peak Demand Season Approaches, the Textile Market in China Will Improve
-
Homovanillic Acid: Properties, Medical & Laboratory Applications
-
Strong Cost Support Drives Robust Rise in Anhydrous Hydrogen Fluoride Market